Strategies for optimizing oxygenation in acute respiratory distress syndrome

Clinical Pulmonary Medicine

Volumn 11, Issue 5, 2004, Pages 318-327

  John, Joseph ^a   Idell, Steven ^a  

^a UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

Author keywords

Acute lung injury; Acute respiratory distress syndrome; Hypoxemia

Indexed keywords

ACTIVATED PROTEIN C; ANTIINFECTIVE AGENT; ANTIOXIDANT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; CYCLIC GMP; DAZOXIBEN; DOPAMINE RECEPTOR STIMULATING AGENT; GAMMA LINOLENIC ACID; IBUPROFEN; ICOSAPENTAENOIC ACID; KETOCONAZOLE; LUNG SURFACTANT; METHYLPREDNISOLONE; NITRIC OXIDE; PENTOXIFYLLINE; PHOSPHODIESTERASE INHIBITOR; PROSTAGLANDIN E1;

ACUTE DISEASE; ACUTE RESPIRATORY FAILURE; ADULT RESPIRATORY DISTRESS SYNDROME; ARTIFICIAL VENTILATION; CRITICAL ILLNESS; DIET SUPPLEMENTATION; GAS EXCHANGE; HIGH FREQUENCY VENTILATION; HUMAN; HYPOXEMIA; IATROGENIC DISEASE; LIQUID VENTILATION; LUNG INJURY; OXYGENATION; PATIENT POSITIONING; PNEUMONIA; POSITIVE END EXPIRATORY PRESSURE; PRESSURE CONTROL VENTILATION; RESPIRATORY DISTRESS SYNDROME; REVIEW; SEPSIS; TIDAL VOLUME; VENTILATOR; VENTILATOR ASSOCIATED PNEUMONIA;

EID: 4644341546     PISSN: 10680640     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cpm.0000140180.71681.79     Document Type: Review

References (78)

1. Petty TL, Ashbaugh DG. The adult respiratory distress syndrome: clinical features, factors influencing prognosis and principles of management. Chest. 1971;60:233-239.
2. Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994;149:818-824.
3. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000;342:1301-1308.
4. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis: the ACCP/SCCM Consensus Conference Committee: American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101:1644-1655.
5. Baue AE. Multiple, progressive, or sequential systems failure: a syndrome of the 1970s. Arch Surg. 1975;110:779-781.
6. Bachofen H, Schurch S, Urbinelli M, et al. Relations among alveolar surface tension, surface area, volume, and recoil pressure. J Appl Physiol. 1987;62:1878-1887.
7. Dreyfuss D, Soler P, Basset G, et al. High inflation pressure pulmonary edema: respective effects of high airway pressure, high tidal volume, and positive end-expiratory pressure. Am Rev Respir Dis. 1988;137:1159-1164.
8. Slutsky AS, Tremblay LN. Multiple system organ failure: is mechanical ventilation a contributing factor? Am J Respir Crit Care Med. 1998;157:1721-1725.
9. Taskar V, John J, Evander E, et al. Surfactant dysfunction makes lungs vulnerable to repetitive collapse and reexpansion. Am J Respir Crit Care Med. 1997;155:313-320.
10. Ranieri VM, Giuliani R, Fiore T, et al. Volume-pressure curve of the respiratory system predicts effects of PEEP in ARDS: "occlusion" versus "constant flow" technique. Am J Respir Crit Care Med. 1994;149:19-27.
11. Ranieri VM, Eissa NT, Corbeil C, et al. Effects of positive end-expiratory pressure on alveolar recruitment and gas exchange in patients with the adult respiratory distress syndrome. Am Rev Respir Dis. 1991;144:544-551.
12. Muscedere JG, Mullen JB, Gan K, et al. Tidal ventilation at low airway pressures can augment lung injury. Am J Respir Crit Care Med. 1994;149:1327-1334.
13. Gattinoni L, Pesenti A, Avalli L, et al. Pressure-volume curve of total respiratory system in acute respiratory failure: computed tomographic scan study. Am Rev Respir Dis. 1987;136:730-736.
14. Amato MB, Barbas CS, Medeiros DM, et al. Effect of a protective- ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med. 1998;338:347-354.
15. Suter PM, Fairley HB, Isenberg MD, et al. Optimum end-expiratory airway pressure in patients with acute pulmonary failure. N Engl J Med. 1975;292:284-289.
16. Lightwarck-Aschoff M, Mois G, Hedlund A, et al. Compliance is nonlinear over tidal volume irrespective of positive end-expiratory pressure level in surfactant depleted piglets. Am J Respir Crit Care Med. 2000;162:2125-2133.
17. Brochard L, Roudot-Thoraval F, Roupie E, et al. Tidal volume reduction for prevention of ventilation-induced lung injury in acute respiratory distress syndrome: the Multicenter Trail Group on Tidal Volume reduction in ARDS. Am J Respir Crit Care Med. 1998;158:1831-1838.
18. Brower RG, Shanholtz CB, Fessler HE, et al. Prospective, randomized, controlled clinical trial comparing traditional versus reduced tidal volume ventilation in the acute respiratory distress syndrome patients. Crit Care Med. 1999;27:1492-1498.
19. Stewart TE, Meade MO, Cook DJ, et al. Evaluation of a ventilation strategy to prevent barotrauma in patients at high risk for acute respiratory distress syndrome: Pressure- and Volume-Limited Ventilation Strategy Group. N Engl J Med. 1998;338:355-361.
20. Gattinoni L, Vagginelli F, Chiumello D. Physiologic rationale for ventilator setting in acute lung injury/acute respiratory distress syndrome patients. Crit Care Med. 2003;31:S300-304.
21. Fort P, Farmer C, Westerman J, et al. High-frequency oscillatory ventilation for adult respiratory distress syndrome: a pilot study. Crit Care Med. 1997;25:937-947.
22. Rappaport SH, Shipner R, Yoshihara G, et al. Randomized, prospective trial of pressure-limited versus volume-controlled ventilation in severe respiratory failure. Crit Care Med. 1994;22:22-32.
23. Jolliet P, Bulpa P, Ritz M, et al. Additive beneficial effects of the prone position, nitric oxide, and almitrine bismesylate on gas exchange and oxygen transport in acute respiratory distress syndrome. Crit Care Med. 1997;25:786-794.
24. Servillo G, Roupie E, De Robertis E, et al. Effects of ventilation in ventral decubitus position on respiratory mechanics in adult respiratory distress syndrome. Intensive Care Med. 1997;23:1219-1224.
25. Guerin C, Badet M, Rosselli S, et al. Effects of prone position on alveolar recruitment and oxygenation in acute lung injury. Intensive Care Med. 1999;25:1222-1230.
26. Flaatten H, Aardal S, Hevroy O. Improved oxygenation utilizing the prone position in patients with ARDS. Acta Anesthesiol Scand. 1998;42:329-334.
27. Vollman KM, Bander JJ. Improved oxygenation using a prone positioner in patients with acute respiratory distress syndrome. Intensive Care Med. 1996;22:1105-1111.
28. Gattinoni L, Tognoni G, Pesenti A, et al. Effect of prone positioning on the survival of patients with acute respiratory failure. N Engl J Med. 2001;345:568-573.
29. Pepke-Zaba J, Higenbottam TW, Dinh-Xuan AT, et al. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet. 1991;338:1173-1174.
30. Rossaint R, Falke KJ, Lopez F, et al. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med. 1993;328:399-405.
31. Barbera JA, Roger N, Roca J, et al. Worsening of pulmonary gas exchange with nitric oxide inhalation in chronic obstructive pulmonary disease. Lancet. 1996;347:436-440.
32. Benzing A, Brautigam P, Geiger K, et al. Inhaled nitric oxide reduces pulmonary transvascular albumin flux in patients with acute lung injury. Anesthesiology. 1995;83:1153-1161.
33. Poss WB, Timmons OD, Farrukh IS, et al. Inhaled nitric oxide prevents the increase in pulmonary vascular permeability caused by hydrogen peroxide. J Appl Physiol. 1995;79:886-891.
34. Chollet-Martin S, Gatecel C, Kermarrec N, et al. Alveolar neutrophil functions and cytokine levels in patients with the adult respiratory distress syndrome during nitric oxide inhalation. Am J Respir Crit Care Med. 1996;153:985-990.
35. Bhorade S, Christenson J, O'Connor M, et al. Response to inhaled nitric oxide in patients with acute right heart syndrome. Am J Respir Crit Care Med. 1999;159:571-579.
36. Michael JR, Barton RG, Saffle JR, et al. Inhaled nitric oxide versus conventional therapy: effect on oxygenation in ARDS. Am J Respir Crit Care Med. 1998;157:1372-1380.
37. Troncy E, Collet JP, Shapiro S, et al. Inhaled nitric oxide in acute respiratory distress syndrome: a pilot randomized controlled study. Am J Respir Crit Care Med. 1998;157:1483-1488.
38. Dellinger RP, Zimmerman JL, Taylor RW, et al. Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial: Inhaled Nitric Oxide in ARDS Study Group. Crit Care Med. 1998;26:15-23.
39. Goupe d'Etude sur le NO Inhale au Cours de l'ARDS (GENOA). Inhaled NO in ARDS: presentation of a double blind randomized multicentric study [abstract]. Am J Respir Crit Care Med. 1996;153: A590.
40. Lundin S, Mang H, Smithies M, et al. Inhalation of nitric oxide in acute lung injury: results of a European multicentre study: the European Study Group of Inhaled Nitric Oxide. Intensive Care Med. 1999;25:911-919.
41. Gerlach H, Keh D, Semmerow A, et al. Dose-response characteristics during long-term inhalation of nitric oxide in patients with severe acute respiratory distress syndrome: a prospective, randomized, controlled study. Am J Respir Crit Care Med. 2003;167:1008-1015.
42. Lu Q, Mourgeon E, Law-Koune JD, et al. Dose-response curves of inhaled nitric oxide with and without intravenous almitrine in nitric oxide-responding patients with acute respiratory distress syndrome. Anesthesiology. 1995;83:929-943.
43. Papazian L, Bregeon F, Gaillat F, et al. Does norepinephrine modify the effects of inhaled nitric oxide in septic patients with acute respiratory distress syndrome? Anesthesiology. 1998;89:1089-1098.
44. Ziegler JW, Ivy DD, Fox JJ, et al. Dipyridamole potentiates pulmonary vasodilatation induced by acetylcholine and nitric oxide in the ovine fetus. Am J Respir Crit Care Med. 1998;157:1104-1110.
45. Kinsella JP, Truog WE, Walsh WF, et al. Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn. J Pediatr. 1997;131:55-62.
46. Houmes RJ, Hartog A, Verbrugge SJ, et al. Combining partial liquid ventilation with nitric oxide to improve gas exchange in acute lung injury. Intensive Care Med. 1997;23:163-169.
47. Chastre J, Fagon J-Y. Ventilator-associated pneumonia: state of the art. Am J Respir Crit Care Med. 2002;165:867-903.
48. Rouby JJ, Laurent P, Gosnach M, et al. Risk factors and clinical relevance of nosocomial maxillary sinusitis in the critically ill. Am J Respir Crit Care Med. 1994;150:776-783.
49. Valles J, Artigas A, Rello J, et al. Continuous aspiration of subglottic secretions in preventing ventilator-associated pneumonia. Ann Intern Med. 1995;122:179-186.
50. Fink MP, Helsmoortel CM, Stein KL, et al. The efficacy of an oscillating bed in the prevention of lower respiratory tract infection in critically ill victims of blunt trauma: a prospective study. Chest. 1990;97:132-137.
51. Antonelli M, Conti G, Rocco M, et al. A comparison of noninvasive positive-pressure ventilation and conventional mechanical ventilation in patients with acute respiratory failure. N Engl J Med. 1998;339:429-435.
52. Sugerman HJ, Wolfe L, Pasquale MD, et al. Multicenter, randomized, prospective trial of early tracheostomy. J Trauma. 1997;43:741-747.
53. Bernard GR, Luce JM, Sprung CL, et al. High-dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med. 1987;317:1565-1570.
54. Weigelt JA, Norcross JF, Borman KR, et al. Early steroid therapy for respiratory failure. Arch Surg. 1985;120:536-540.
55. Schonfeld SA, Ploysongsang Y, DiLisio R, et al. Fat embolism prophylaxis with corticosteroids: a prospective study in high-risk patients. Ann Intern Med. 1983;99:438-443.
56. The National Institutes of Health-University of California Expert Panel for Corticosteroids as Adjunctive Therapy for Pneumocystis pneumonia. Consensus statement on the use of corticosteroids as adjunctive therapy for Pneumocystis pneumonia in the acquired immunodeficiency syndrome. N Engl J Med. 1990;323:1500-1504.
57. Meduri GU, Headley AS, Golden E, et al. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA. 1998;280:159-165.
58. Hirschl RB, Pranikoff T, Wise C, et al. Initial experience with partial liquid ventilation in adult patients with the acute respiratory distress syndrome. JAMA. 1996;275:383-389.
59. Bartlett RH, Hirschl RB. Liquid ventilation in ARDS. Acta Anaesthesiol Scand Suppl. 1997;111:68-69.
60. Hirschl RB, Croce M, Gore D, et al. Prospective, randomized, controlled pilot study of partial liquid ventilation in adult respiratory distress syndrome. Am J Respir Crit Care Med. 2002;165:781-787.
61. Kandler MA, von der Hardt K, Schoof E, et al. Persistent improvement of gas exchange and lung mechanics by aerosolized perfluorocarbon. Am J Respir Crit Care Med. 2001;164:31-35.
62. Gregory TJ, Steinberg KP, Spragg R, et al. Bovine surfactant therapy for patients with acute respiratory distress syndrome. Am J Respir Crit Care Med. 1997;155:1309-1315.
63. Spragg RG, Gilliard N, Richman P, et al. Acute effect of a single dose of porcine surfactant on patients with the adult respiratory distress syndrome. Chest. 1994;105:195-202.
64. Anzueto A, Baughmann RP, Guntupalli KK, et al. Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome: Exosurf Acute Respiratory Distress Syndrome Sepsis Study Group. N Engl J Med. 1996;334:1417-1421.
65. Spragg RG, Lewis JF, Wurst W, et al. Treatment of acute respiratory distress syndrome with recombinant surfactant protein C surfactant. Am J Respir Crit Care Med. 2003;167:1562-1566.
66. Lewis JF, Brackenbury A. Role of exogenous surfactant in acute lung injury. Crit Care Med. 2003;31:S324-328.
67. Jepsen S, Herlevsen P, Knudsen P, et al. Antioxidant treatment with N-acetylcysteine during adult respiratory distress syndrome: a prospective, randomized, placebo-controlled study. Crit Care Med. 1992;20:918-923.
68. Montravers P, Fagon JY, Gilbert C, et al. Pilot study of cardiopulmonary risk from pentoxifylline in adult respiratory distress syndrome. Chest. 1993;103:1017-1022.
69. Bernard GR, Wheeler AP, Russell JA, et al. The effects of ibuprofen on the physiology and survival of patients with sepsis: the Ibuprofen in Sepsis Study Group. N Engl J Med. 1997;336:912-918.
70. Leeman M, Boeynaems JM, Degaute JP, et al. Administration of dazoxiben, a selective thromboxane synthetase inhibitor, in the adult respiratory distress syndrome. Chest. 1985;87:726-730.
71. The ARDS Network. Ketoconazole for early treatment of acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA. 2000;283:1995-2002.
72. Abraham E, Baughman R, Fletcher E, et al. Liposomal prostaglandin E1 (TLC C-53) in acute respiratory distress syndrome: a controlled, randomized, double-blind, multicenter clinical trial: TLC C-53 ARDS Study Group. Crit Care Med. 1999;27:1478-1485.
73. Gadek JE, DeMichele SJ, Karlstad MD, et al. Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome: Enteral Nutrition in ARDS Study Group. Crit Care Med. 1999;27:1409-1429.
74. Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001;344:699-709.
75. Berthiaume Y, Folkesson HG, Matthay MA. Lung edema clearance: invited review: alveolar edema fluid clearance in the injured lung. J Appl Physiol. 2002;93:2207-2213.
76. Saldias F, Lecuona E, Friedman E, et al. Modulation of lung liquid clearance by isoproterenol in rat lungs. Am J Physiol. 1998;274:L694-L701.
77. Adir Y, Sznajder JI. Regulation of lung edema clearance by dopamine. Isr Med Assoc J. 2003;5:47-50.
78. Adir Y, Factor P, Dumasius V, et al. Na,K-ATPase gene transfer increases liquid clearance during ventilation-induced lung injury. Am J Respir Crit Care Med. 2003;168:1445-1448.